Keyphrases
Rift Valley Fever Virus
100%
MP-12
43%
Rift Valley Fever
30%
Rift Valley Fever Vaccine
24%
Virus
24%
MP-12 Vaccine
22%
NSs Protein
20%
Phlebovirus
20%
Ruminants
16%
Live Attenuated
16%
Recombinant
15%
S Segment
15%
Ebola Virus
14%
Reston
12%
M Segment
12%
Bunyaviridae Family
11%
Virus Infection
11%
Protein Kinase PKR
11%
Recombinant nucleoprotein
10%
Nucleoprotein
10%
NS Gene
10%
Virus Strains
10%
Nipah Virus
9%
Infected Cells
9%
Attenuation
9%
Hemorrhagic Fever
9%
L Segment
9%
Enzyme-linked Immunosorbent Assay (ELISA)
8%
Virus Subtypes
8%
Africa
8%
Bunyavirus
8%
Reverse Genetics
8%
Virulence Factors
8%
Ebola
8%
Vaccine Strain
8%
Mosquito-borne
7%
Abortion
7%
Philippines
7%
Encephalitis
7%
Immunofluorescence Assay
7%
RNA Synthesis
6%
Mouse Model
6%
Vaccination
6%
Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
6%
Viral Replication
6%
Arabian Peninsula
6%
Protein Expression
6%
Toscana Virus
5%
Host mRNA
5%
Vaccine Candidate
5%
Immunology and Microbiology
Rift Valley Fever Virus
95%
Rift Valley Fever
46%
Phlebovirus
25%
Viral Disease
21%
Bunyaviridae
20%
Nucleoprotein
19%
Ebola Virus
12%
Wild Type
12%
Enzyme-Linked Immunosorbent Assay
10%
Virus Strain
10%
interferon
10%
Hemorrhagic Fever
10%
Virulence Factor
9%
Nipah Virus
8%
Viral Replication
8%
Zoonosis
7%
Encephalitis
7%
Downregulation
6%
Immunofluorescence
6%
Mouse Model
6%
Crimean-Congo Hemorrhagic Fever Virus
6%
Protein Expression
6%
Immunoglobulin G
6%
Gene Expression
6%
Glycoprotein
5%
Cell Culture
5%
Initiation Factor 2
5%
Host Cell
5%
Promoter Region
5%